smartbpm intellectual tonometer kseniia shipulina ceo argus [email protected] +7 922 317...
TRANSCRIPT
PROBLEM
2 bln of people, suffer from cardiovascular diseases all over the globe
A lack of adequate control of risk factors
Risk factors quickly change in time
Some risk factors emerge only at night
2
3
TARGET AUDIENCE (Russia)
1. Hypertensive patients– 42 mln2. Stroke sufferers – 3,8 mln3. High-risk patient group – 28,8 mln4. Their relatives
4
TECHNOLOGY
TonometryHeart rate
Blood velocityVessels hardness
Arterial oxygen percent saturationVolume and power of cardiac output
Occurrence and character of arrhythmia
5
COMPETITORS
Our major competitors - the manufacturers of professional automatic blood pressure monitors(OMRON, A&D, Microlife).
smartBPM Microlife BP A110
A&D TM2655-
P
Omron HEM-907
Operation under heavy workload + +/- + +Adjustment of the functions of other devices within a tonometer + - - -Risk identification of a stroke or heart attack + + - -Wireless data transfer + - - -% of errors
0-3 mm of mercury
1-2 bpm
5-10 mm. 4-10 bpm
5-10 mm. 4-10 bpm
5-10 mm. 4-10 bpm
COMPETITIVE ADVANTAGES
• The opportunity of 24-hour monitoring • Tracking the heart activityAnalysis of 3 large risk factors: hypertension, atherosclerosis, heart rhythm disturbances
• Assistance to the doctor in choosing a treatment method• The opportunity for clinics to get a profit ~$5000 per year for one smartBPM
6
7
BUSINESS MODEL
Key partners
Manufactory partnerClinicsDistributorsPharmacy
Key activity
SupportMarketingAds
Value proposition
The opportunity for a patient to protect him/her life from a stroke consequence
Customer relationship
Automated services
Customer segments
Hypertensive patientsStroke suffersHigh-risk factors groupTheir relatives
Key resources TeamCloud service
Channels ClinicsDistributorsPharmacy
CostsSalary and rentHosting and communications Manufacturing costs Marketing and ads
RevenueSales of mobile and PC-applications - $2 and $10 per monthSales of tonometer - $140 (for people)Fixed revenue share - $0.5 for one examination
8
MARKETING AND SALES IN RUSSIA
Natural expression – 6,8 mln units Monetary expression – $116 mln
• Marketing activities: Creation of a website with the possibility of
online sales
Search promotion (SEO-optimization)
Contextual advertising
Banner (display) advertising on thematic sites
Publications in a press and thematic periodicals
Handout materials
Participation in thematic exhibitions and conferences
10К 45К 85К 125К 147К0
1
2
3
4
5
6
7
Sales plan
Total cumulative Sales plan
ARGUS TEAM
9
Kseniya Shipulina CEO, marketer
Aron S. Spencer Business advisor
Aleksandr Poleschyuk Technical advisor
Andrey DumlerMedical advisor
Leonid BrokhinMedical advisor
Andrey PlyusninLead developer
Dmitriy KobyakovIndustrial engineer
Aleksey MantsurovIndustrial engineer
10
WE HAVE WE MUST WE EXPECT
Great team Finish the development Entry into the Russian market at the end of
2016
Approved customer needs
Get investment in the amount of 3,3 mln rubles
Entry into the American market at the end of
2018
Find the manufacturing partners
Breakeven results in 2 years
Make an industrial prototype
Obtain the registration certificate
Hire the employees
WE OFFER
Become our partner and we will make the best professional blood pressure monitor in the world!
INVESTMENT
11
Certification of the device 16 220,2
Obtainment of a certificate for registration of a computer program 196,1
Patenting 1 960,7
Industrial design 4 352,9
Salary fund 32 315,6
Marketing and promotion 8 353
Total 66 000
RISK ANALYSIS Risks Approaches to risk reduction
1. Technological risk :
The claimed characteristics with respect to the accuracy of stroke prediction may not be achieved
Improvement of the algorithm, attracting the highly qualified medical and technical experts
Modification of the hardware component to increase the number and quality of sensors.
2. Financial risk:
A lack of investment for commercialization and entry into the market.
Search of partners and investors. Sales of small lots in order to prove the effectiveness of the device. Participation in the competitions of the Foundation for Assistance, for
example, "Commercialization".3. Commercial risk:
A failure to reach the planned targets on sales
Analysis of the responses of actual and potential customers, improvements based on the feedback.
Adjustment of the business model excluding a charge for the supply of hardware.
Promotion at thematic events Development of a more attractive design and finding the ways to
reduce production costs.12
Profits and loses, $K
1 year 2 year 3 year
Total revenue
1 321,4 10 807, 8 32 915,7
Gross profit
- 170,9 5 954,9 24 578,4
OPEX 942,2 101,4 104,7
Pure profits
- 265,2 5 854,8 24 473,2
13
14
ARGUS TODAY
Currently the last stage of the development of the software part is being completed, the prototype is made.
THANK YOU FOR YOUR ATTENTION!
15
Kseniya Shipulina CEO ARGUS
+7 922 317 28 24skype: [email protected]: kseniyashipulinahttp://ru.linkedin.com/in/kseniiashipulina/
16
КЛЮЧЕВЫЕ ПОКАЗАТЕЛИПоказатель Дэдлайн
Исследования и разработки Завершение разработки ПО 2 кв. 2015
Создание продукта Изготовление промышленного прототипа
н. 3 кв. 2015
Общее орг. развитие и план по найму
12 сотрудников 2 кв. 2016
Защита ИС и лицензирование
Получение рег. удостоверения
3 кв. 2015
Патентование 2, 3 кв. 2015
Маркетинг, внедрение, продвижение
Старт реализации маркетингового плана
2 кв. 2015
Привлечение инвестиций Привлечение 3,3М руб. н. 2 кв. 2015